View Older Stories View More Recent Stories

Sep 9, 2022 07:02AM Bausch Health Co. Inc. (BHC) Responds to Tentative FDA Approval of Norwich Pharmaceuticals' 200 mg Rifaximin
Sep 9, 2022 07:00AM Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin
Aug 22, 2022 07:01AM Bausch Health (BHC) Continues Separation of Bausch + Lomb
Aug 22, 2022 07:00AM Bausch Health Continuing Process Toward Separating Bausch + Lomb
Aug 10, 2022 06:09PM Bausch Health Co. Inc. (BHC) to Appeal XIFAXAN Patent Decision
Aug 10, 2022 06:00PM Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit
Aug 10, 2022 07:00AM Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)
Aug 9, 2022 07:00AM BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS
Jul 28, 2022 03:46PM Bausch Health (BHC) to Appeal Expected Court Decision on Certain XIFAXAN Patents
Jul 28, 2022 03:45PM Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation
Jul 27, 2022 07:35PM Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9
Jul 20, 2022 07:03AM Bausch + Lomb Corporation (BLCO) Announces Leadership Changes
Jul 20, 2022 07:00AM Bausch + Lomb Provides Leadership Update
Jul 13, 2022 07:00AM Salix Announces 2022 Gastrointestinal Health Scholars Program Winners
Jun 23, 2022 04:54PM Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors
Jun 21, 2022 07:00AM Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation
Jun 20, 2022 07:00AM Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022
Jun 16, 2022 05:32PM Bausch Health Co. Inc. (BHC) Suspending IPO of Solta Medical
Jun 16, 2022 05:30PM Bausch Health Provides Update on Solta Medical
May 18, 2022 07:00AM Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
May 11, 2022 07:00AM Bausch Health Announces Participation In Upcoming Investor Conferences
May 10, 2022 06:59AM Bausch Health Companies Inc. Announces First-Quarter 2022 Results
May 6, 2022 12:14PM Bausch Health Co. Inc. (BHC) Appoints Thomas J. Appio as CEO
May 6, 2022 12:08PM Bausch Health Announces Thomas J. Appio As Chief Executive Officer
May 3, 2022 07:00AM Bausch Health Co. Inc. (BHC) Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03
May 3, 2022 06:59AM Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting
Apr 29, 2022 07:00AM Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10
Apr 28, 2022 06:50AM Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting
Apr 27, 2022 04:32PM Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference
Apr 25, 2022 06:59AM Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
Apr 21, 2022 06:59AM Bausch + Lomb Reports More Than 48 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
Apr 20, 2022 07:00AM Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health
Apr 18, 2022 06:59AM Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting
Apr 7, 2022 08:06AM SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
Apr 4, 2022 06:30AM HALF OF IBS PATIENTS SURVEYED REPORT IBS SYMPTOMS MORE CHALLENGING TO MANAGE IN THE PAST YEAR
Mar 29, 2022 07:10AM Bausch Health Co. (BHC) Will Reduce Debt By $200 Million
Mar 29, 2022 07:00AM Bausch Health Will Reduce Debt By $200 Million
Mar 28, 2022 06:59AM Bausch Health Co. Inc. (BHC) and Clearside (CLSD) Announce US Launch of XIPERE
Mar 28, 2022 06:59AM Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associa
Mar 24, 2022 07:02AM Bausch Health Co. Inc. (BHC) Reports Publication of New Data on Cost Impact of Treating Opioid-Induced Constipation Including Salix's RELISTOR
Mar 24, 2022 07:00AM New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency De
Mar 22, 2022 04:08PM Bausch Health's (BHC) Solta Appoints Gary Gemignani as CFO
Mar 22, 2022 04:05PM Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer
Mar 22, 2022 06:59AM Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting
Mar 3, 2022 07:00AM Bausch Health Announces Participation in Upcoming Investor Conferences
Mar 2, 2022 06:59AM Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program
Mar 1, 2022 07:00AM Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings
Feb 24, 2022 07:00AM Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference
Feb 23, 2022 06:59AM Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance
Feb 22, 2022 06:59AM OraPharma Launches OraFit™ Custom Clear Dental Aligner System
View More Recent Stories View Older Stories